CDC Website CDC Website

To Join the NPIN community or

You are here

Antiretroviral Drugs

Guide for HIV/AIDS Clinical Care

NPIN admin's picture

This manual for clinicians provides guidelines for clinical care of persons with HIV/AIDS. This updated version incorporates many new insights, but the time-tested format has been retained – easy access to crucial facts for a busy clinician. The guide touches on every topic facing people with HIV and their caregivers.

Adherencia al Regimen Terapeutico Para el VIH

NPIN admin's picture
This information sheet discusses the importance of adhering to an HIV treatment regimen. It lists steps that should be taken before beginning treatment to help the patient maintain adherence and suggestions to help the patient after beginning treatment. It advises contacting the doctor if adhering to treatment is a problem as the doctor may have other treatment options.

HIV/AIDS in the Lives of Gay and Bisexual Men in the United States

NPIN admin's picture
This report summarizes the findings of survey of gay and bisexual men in the U.S. that focused on their attitudes, knowledge, and experiences with HIV/AIDS and new HIV therapies. The study was conducted to find out what gay and bisexual men knew and thought about HIV, new treatments, and the obstacles to taking them.

Opportunistic Infections (OIs) in HIV/AIDS

NPIN admin's picture

This poster summarizes the guidelines for prevention and treatment of selected opportunistic infections (OIs). It contains a table with available dosage forms and food requirements of drugs and discusses the most common OIs.

Post-Exposure Prophylaxis (PEP) in Pediatrics/Adolescents

NPIN admin's picture

This poster was developed from a variety of resources and includes management of exposures, study findings related to exposure, important discussion points when assessing the exposed individual, recommended antiretroviral (ARV) regimens for post-exposure prophylaxis (PEP) of HIV, ARV adverse effects, hepatitis B PEP, and hepatitis C post-exposure management.

MMWR: Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors

NPIN admin's picture
This report presents updated data pertaining to drug-drug-interactions between protease inhibitors and nonnucleoside reverse transcriptase inhibitors (NNRTIs) for treatment of HIV and rifamycins for the treatment of TB. The notice also presents recommendations for the use of these drugs. New data indicate that rifampin can be used for the treatment of active TB in three situations.

A Public Health Approach for Scaling up Antiretroviral (ARV) Treatment: A Toolkit for Programme Managers

NPIN admin's picture
This monograph is a toolkit for planning and implementing antiretroviral (ARV) treatment programs in resource-limited settings by providing technical guidance on planning treatment programs. It lists the goals of an ARV treatment program as reducing illnesses and death due to HIV/AIDS, providing safe and effective treatment, working towards providing universal access to treatment, making the best possible use of resources, and integrating ARV treatment with other public health resources.

Handbook on Access to HIV/AIDS-Related Treatment: A Collection of Information, Tools and Resources for NGOs, CBOs and PLWHA Groups

NPIN admin's picture
This monograph seeks to build practical skills for nongovernmental organizations (NGOs), community-based organizations (CBOs), and groups of people living with HIV that are responding to HIV/AIDS in developing countries. It is designed to help NGOs, CBOs, and PLWHA groups improve the quality of their work on HIV/AIDS-related treatment. Chapter one helps groups understand key terms, links between HIV/AIDS-related treatment and HIV prevention, factors affecting access to HIV/AIDS-related treatment, and barriers to treatment access. Chapter two focuses on the foundations of treatment.

Treating 3 Million by 2005: Making It Happen: The WHO Strategy

NPIN admin's picture
This report describes the goal, target, guiding principles, and action steps of the World Health Organization’s (WHO) plan to complete the 3 by 5 Initiative. The target of the WHO and Joint United Nations Programme on HIV/AIDS 3 by 5 Initiative is to provide antiretroviral drug therapy to 3 million people with HIV/AIDS in developing countries by the end of 2005.

Pages

Subscribe to RSS - Antiretroviral Drugs